Literature DB >> 8062157

Comparison of bone formation rates measured by radiocalcium kinetics and double-tetracycline labeling in maintenance dialysis patients.

M Cochran1, M Cochran1, A Neville, E A Marshall.   

Abstract

We report 23 prospective studies on 18 maintenance dialysis patients in whom we measured skeletal mineralization rate (m) using 47Ca, analyzed by the expanding pool model, and compared it with the histologic bone formation rate (bfr), volume referent, estimated on tetracycline-labeled iliac crest bone. The patients showed a spectrum of bone disease types including adynamic bone, aluminum-related osteomalacia, and various degrees of secondary hyperparathyroidism. The mean width between double labels, on which mineral apposition rate depended, was estimated using a simple formula relating area to perimeter for each feature enclosed by the labels. Values for m ranged from 0 to 155 mmol calcium per day and for bfr from 0 to 124% per year. There was close correlation between m and bfr (r = 0.976), serum alkaline phosphatase (r = 0.968), and serum immunological parathyroid hormone (iPTH) (r = 0.868). When the volumetric bfr was converted to mass units and applied to the whole skeleton, using literature values for mineral density and cortical and trabecular mass, there was close agreement between the histologic and isotopic estimates of m (r = 0.959). The results validate the two methods and suggest they are interchangeable. However, use of a rigorous method to determine bfr appears to be essential.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8062157     DOI: 10.1007/bf00305526

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  28 in total

1.  CALCIUM ACCRETION AND BONE FORMATION IN DOGS: AN EXPERIMENTAL COMPARISON BETWEEN THE RESULTS OF CA-45 KINETIC ANALYSIS AND TETRACYCLINE LABELLING.

Authors:  W R LEE; J H MARSHALL; H A SISSONS
Journal:  J Bone Joint Surg Br       Date:  1965-02

2.  The assessment of bone formation and bone resorption in osteoporosis: a comparison between tetracycline-based iliac histomorphometry and whole body 85Sr kinetics.

Authors:  J Reeve; M E Arlot; P M Chavassieux; C Edouard; J R Green; R Hesp; M Tellez; P J Meunier
Journal:  J Bone Miner Res       Date:  1987-12       Impact factor: 6.741

Review 3.  The biochemistry and the physiology of the tetracyclines: with special reference to mineralized tissues.

Authors:  K H Ibsen; M R Urist
Journal:  Clin Orthop Relat Res       Date:  1964 Jan-Feb       Impact factor: 4.176

4.  Bone turnover model based on a continuously expanding exchangeable calcium pool.

Authors:  L Burkinshaw; D H Marshall; C B Oxby; F W Spiers; B E Nordin; M M Young
Journal:  Nature       Date:  1969-04-12       Impact factor: 49.962

5.  Haemodialysis related osteomalacia: a staining method to demonstrate aluminium.

Authors:  M R Buchanan; B U Ihle; C M Dunn
Journal:  J Clin Pathol       Date:  1981-12       Impact factor: 3.411

6.  A new semiautomatic method for quantitative static and dynamic bone histology.

Authors:  H H Malluche; D Sherman; W Meyer; S G Massry
Journal:  Calcif Tissue Int       Date:  1982-09       Impact factor: 4.333

7.  Mechanism of fluorometric analysis of tetracycline involving metal complexation.

Authors:  S T Day; W G Crouthamel; L C Martinelli; J K Ma
Journal:  J Pharm Sci       Date:  1978-11       Impact factor: 3.534

8.  Calcium metabolism evaluated by 47Ca kinetics: estimation of dermal calcium loss.

Authors:  P Charles; F T Jensen; L Mosekilde; H H Hansen
Journal:  Clin Sci (Lond)       Date:  1983-10       Impact factor: 6.124

9.  Regional measurement of bone calcium accretion rate and exchangeable pool with a whole-body counter: method and studies in subjects without bone disease.

Authors:  P Bergmann; T Paternot; A Schoutens
Journal:  Calcif Tissue Int       Date:  1983       Impact factor: 4.333

10.  Irreversible bone loss in osteomalacia. Comparison of radial photon absorptiometry with iliac bone histomorphometry during treatment.

Authors:  A M Parfitt; D S Rao; J Stanciu; A R Villanueva; M Kleerekoper; B Frame
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.